1.
ERJ Open Res
; 7(1)2021 Jan.
Artículo
en Inglés
| MEDLINE
| ID: mdl-33816604
RESUMEN
ERBB4 fusion is a rare, novel oncogenic event involved in the development of lung adenocarcinoma that is not routinely looked for, although ERBB4 fusion is a potential target for existing pan-ErbB tyrosine kinase and must be implemented in the laboratory https://bit.ly/3nYmGQ9.
